| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 357704 | Cyanomorpholinodoxorubicin | 0.00404192617431249 | 0.73034184 |
| NSC 606172 | Camptothecin Derivative | 0.00404192617431249 | 0.82884158 |
| NSC 606985 | Camptothecin Derivative | 0.00404192617431249 | 0.89357449 |
| NSC 623520 | Null | 0.00404192617431249 | 0.22706192 |
| NSC 646127 | 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- | 0.00404192617431249 | 0.038359249 |
| NSC 658103 | Null | 0.00404192617431249 | 0.57603977 |
| NSC 679800 | Null | 0.00404192617431249 | 0.18852526 |
| NSC 704533 | Null | 0.00404192617431249 | 0.66485026 |
| NSC 725775 | 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride | 0.00404192617431249 | 0.67697886 |
| NSC 735036 | 6-[3-(2-Hydroxyethyl)-methylamino-1-propyl]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]iso quinoline Hydrochloride | 0.00404192617431249 | 0.58836762 |